small and mid cap biotech companies

1 statements across 1 episodes · 1 bullish · 0 bearish · 1 people on the record · first statement Oct 6, 2022 by Andy Acker · across every show →

Everything said about small and mid cap biotech companies, oldest first

Oct 6, 2022 positive
Assertion Supported
Acker: Small and mid-cap biotechs develop over 60% of new medicines
“Over 60% of the new medicines that reach the market today were developed by small and mid cap biotech companies.”
Andy Acker Oct 6, 2022 ▶ 35:36 Andy Acker - Empty Rooms: Investing in Biotech at Janus Henderson (Capital Allocators, EP.274)
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 700 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.